General MedicationsTRANSDERMALStandard
TESTOSTERONE
TESTOSTERONE
Standard Dose
1.62% (20.25MG/1.25GM PACKET)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview TESTOSTERONE is listed in Drugs@FDA under application 205781 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient TESTOSTERONE Form and strength GEL;TRANSDERMAL - 1.62% (20.25MG/1.25GM PACKET) Sponsor PADAGIS ISRAEL Submission history Latest submission status date: 2019-06-27 00:00:00.
Structured Monograph
Clinical summary
Approval overview TESTOSTERONE is listed in Drugs@FDA under application 205781 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TESTOSTERONE Form and strength GEL;TRANSDERMAL - 1.62% (20.25MG/1.25GM PACKET) Sponsor PADAGIS ISRAEL Submission history Latest submission status date: 2019-06-27 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.